These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 7724709
1. Expanding psychopharmacologic treatment options for the depressed medical patient. Stoudemire A. Psychosomatics; 1995; 36(2):S19-26. PubMed ID: 7724709 [Abstract] [Full Text] [Related]
2. Psychopharmacologic treatment of depression in the medically ill. Beliles K, Stoudemire A. Psychosomatics; 1998; 39(3):S2-19. PubMed ID: 9664784 [Abstract] [Full Text] [Related]
3. New antidepressant drugs and the treatment of depression in the medically ill patient. Stoudemire A. Psychiatr Clin North Am; 1996 Sep; 19(3):495-514. PubMed ID: 8856814 [Abstract] [Full Text] [Related]
4. Pharmacotherapy of affective disorders in old age. Tourigny-Rivard MF. Can J Psychiatry; 1997 Jun; 42 Suppl 1():10S-18S. PubMed ID: 9220125 [Abstract] [Full Text] [Related]
5. [New antidepressive drugs in comparison with classical tricyclics. Mechanism of action and clinical evaluation]. Broocks A, Junghanns K, Thiel A, Gleiter CH, Bandelow B. Fortschr Neurol Psychiatr; 2000 Jan; 68(1):17-24. PubMed ID: 10705571 [Abstract] [Full Text] [Related]
8. [Clinically relevant drug interactions with new generation antidepressants and antipsychotics]. Eckert A. Ther Umsch; 2009 Jun; 66(6):485-92. PubMed ID: 19496045 [Abstract] [Full Text] [Related]
9. Depression in medical illness. Workshop report. Paykel E. Int Clin Psychopharmacol; 1993 Jan; 7(3-4):205-7. PubMed ID: 8468445 [No Abstract] [Full Text] [Related]
10. SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depression. Kent JM. Lancet; 2000 Mar 11; 355(9207):911-8. PubMed ID: 10752718 [Abstract] [Full Text] [Related]
11. [Therapy of post-stroke depression with fluoxetine. A pilot project]. Stamenkovic M, Schindler S, Kasper S. Nervenarzt; 1996 Jan 11; 67(1):62-7. PubMed ID: 8676990 [Abstract] [Full Text] [Related]
12. Clinically relevant interactions between newer antidepressants and second-generation antipsychotics. Spina E, de Leon J. Expert Opin Drug Metab Toxicol; 2014 May 11; 10(5):721-46. PubMed ID: 24494611 [Abstract] [Full Text] [Related]
13. Efficacy in long-term treatment of depression. Montgomery SA. J Clin Psychiatry; 1996 May 11; 57 Suppl 2():24-30. PubMed ID: 8626360 [Abstract] [Full Text] [Related]
14. Recent pharmacologic advances in antidepressant therapy for the elderly. Preskorn SH. Am J Med; 1993 May 24; 94(5A):2S-12S. PubMed ID: 8503477 [Abstract] [Full Text] [Related]
16. Therapeutic options for treating major depression, and the role of venlafaxine. Scott MA, Shelton PS, Gattis W. Pharmacotherapy; 1996 May 24; 16(3):352-65. PubMed ID: 8726593 [Abstract] [Full Text] [Related]
17. New antidepressants and the cytochrome P450 system: focus on venlafaxine, nefazodone, and mirtazapine. Owen JR, Nemeroff CB. Depress Anxiety; 1998 May 24; 7 Suppl 1():24-32. PubMed ID: 9597349 [Abstract] [Full Text] [Related]